Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, is partnering with Canopy Growth Corp. (NASDAQ: CGC) to distribute Canopy’s Storz & Bickel medical line of vaporizers. The two companies entered a distribution agreement outlining plants for Flora Growth’s subsidiary, Australian Vaporizers, to distribute the vaporizers throughout Australia, marking a key expansion of Flora’s footprint in the medical cannabis market in the Land Down Under. Flora will also benefit from Canopy Growth’s well-established global reputation and expertise in the medical cannabis space.
“Canopy Growth is a market leader with a $400 million market capitalization,” said Flora Growth chair and CEO Clifford Starke in the press release. “We are very much interested in partnering with Canopy Growth to bring their highly regarded Storz vaporizers to the Australian market. With Australian Vaporizers at the forefront of this initiative, we are confident that our distribution of Canopy’s Storz products will further enhance the standard of care for medical cannabis patients in Australia.”
To view the full press release, visit https://ibn.fm/vXT6t
About Flora Growth Corp.
Flora Growth is on a mission to become the leading NASDAQ small-cap international cannabis company. The company is a cannabis-focused, consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000-plus points of distribution around the world. For more information about the company, please visit www.FloraGrowth.com.
NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN